Kevin C. Tang's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 500,000 Common Shares done at an average price of $7.9 . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 7.92 per share. | 28 Feb 2025 | 500,000 | 9,929,500 (11%) | 0% | 7.9 | 3,960,000 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 7.85 per share. | 28 Feb 2025 | 399,280 | 8,828,780 (10%) | 0% | 7.9 | 3,134,348 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.02 per share. | 28 Feb 2025 | 351,962 | 9,281,462 (10%) | 0% | 8.0 | 2,822,735 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 28 Feb 2025 | 148,038 | 9,429,500 (11%) | 0% | 8 | 1,184,304 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 7.97 per share. | 28 Feb 2025 | 100,720 | 8,929,500 (10%) | 0% | 8.0 | 802,738 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 28 Feb 2025 | 100,000 | 10,029,500 (11%) | 0% | 8.1 | 809,000 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 9.09 per share. | 05 Dec 2024 | 500,000 | 8,429,500 (9%) | 0% | 9.1 | 4,545,000 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 9.01 per share. | 05 Dec 2024 | 400,000 | 7,929,500 (9%) | 0% | 9.0 | 3,604,000 | Common Shares |
| Aurinia Pharmaceuticals Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.91 per share. | 05 Dec 2024 | 300,000 | 7,529,500 (8%) | 0% | 8.9 | 2,673,000 | Common Shares |